NFKB1 and gastric cancer: As supported by analyses of gastric cancer patient tissues and in vitro experiments using human gastric cancer cell lines BGC823 and SGC7901, TRIM59 promoted the degradation of TRAF6, a member of the TRAF family, via ubiquitination, thus inhibiting the NF-κB signaling pathway [147].